title: High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin.
authors.forename: Massimo
authors.initials: M
authors.lastname: Magagnoli
authors.forename: Giovanna
authors.initials: G
authors.lastname: Masci
authors.forename: Luca
authors.initials: L
authors.lastname: Castagna
authors.forename: Stefania
authors.initials: S
authors.lastname: Bramanti
authors.forename: Emanuela
authors.initials: E
authors.lastname: Morenghi
authors.forename: Carlo
authors.initials: C
authors.lastname: Carnaghi
authors.forename: Armando
authors.initials: A
authors.lastname: Santoro
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006487:Hemostasis; D006801:Humans; D015994:Incidence; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D002955:Leucovorin; D005472:Fluorouracil